Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
Explore this paper's citation graph
Summary
There remains a substantial subgroup of patients who manifest clinical evidence of heart failure despite the first two of these treatments, despite survival after acute myocardial infarction being enhanced by treatment with thrombolytic agents, aspirin, and Beta -adrenoceptor blockade.
- Type
- article
- Published
- 1993-10-02
- Cited by
- 1,849
- References
- 29
- OpenAlex
- https://openalex.org/W2747176423
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:57599036
Keywords
Medicine, Myocardial infarction, Ramipril, Aspirin, Heart failure
References
- Prognosis after recovery from acute myocardial infarction.
- Ventricular remodeling after myocardial infarction.
- Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man.
- Beta blockade during and after myocardial infarction: an overview of the randomized trials.
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
- Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
- Infarct expansion versus extension: two different complications of acute myocardial infarction.
- Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications
- Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
- MEDICAL SCIENCE: GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction
- ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
- Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators.
- Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.
- A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
- Kinetic Properties of the Angiotensin Converting Enzyme Inhibitor Ramiprilat
- Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis.
- The Acute Infarction Ramipril Efficacy (AIRE) Study: Rationale, Design, Organization, and Outcome Definitions
- Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.
- Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction.
- The plight of modern Bushmen.
Cited by
- ACE inhibitors in heart failure. What dose?
- “Escape” of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
- Drug Differences between ACE Inhibitors in Experimental Settings and Clinical Practice
- What is the Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure and after Myocardial Infarction?
- Effects of captopril on ventricular arrhythmias in the early and late phase of suspected acute myocardial infarction. Randomized, placebo-controlled substudy of ISIS-4.
- Clinical aspects of ACE inhibition in patients with acute myocardial infarction
- Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
- Improved endothelial function with angiotensin-converting enzyme inhibitors.
- Left ventricular remodeling: clinical significance and therapy
- Current medical therapy for advanced heart failure.
- Beta-blockade and amiodarone therapy: twin brothers from different parents.
- Has the survival of the heart failure population changed? Lessons from trials.
- Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
- Current medical therapy for advanced heart failure.
- Current concepts in secondary prevention after acute myocardial infarction
- The Kidney in Congestive Heart Failure: Renal Adverse Event Rate of Treatment
- Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?
- A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients.
- Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
Related papers
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
- ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
- Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
- Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
- The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
- A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
- Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
- The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.